Come up with a name for your new list and we'll add to it:
Vtesse was acquired by
Sucampo Pharmaceuticals on April 03, 2017.
Vtesse is a rare disease company dedicated to developing drugs for patients suffering from underserved diseases. Vtesse closely collaborates with National Institutes of Health (NIH), parents, patient …